Konstantina Katcheves is Acadia’s Senior Vice President, Chief Business and Strategy Officer, where she leads business development and corporate strategy, guiding Acadia’s pursuit of strategic partnerships and growth opportunities. She joined the company in August 2025. View All Executive Leadership Team
Ms. Katcheves brings more than two decades of experience in the biopharmaceutical industry, with expertise spanning corporate strategy, mergers and acquisitions, and innovation leadership. Prior to joining Acadia, she served as Senior Vice President, Global Business Development at Teva Pharmaceuticals, where she oversaw the expansion of Teva’s innovative medicines pipeline and built new capabilities to support long-term portfolio growth. She previously held senior executive roles at Bristol Myers Squibb (BMS), including Interim Head of Enterprise Strategy and Business Development. During her tenure at BMS, she led the $14 billion acquisition of Karuna Therapeutics and drove more than $18 billion in announced transactions, advancing both near-term revenue growth and long-term pipeline innovation.
Earlier in her career, Ms. Katcheves held strategic leadership positions at Agilent Technologies and Lonza Group. She holds a Master of Science in Biotechnology from Johns Hopkins University, a Juris Doctor from the University of Oklahoma College of Law, and a Bachelor of Science in Biochemistry and Cell Biology from the University of California, San Diego.